Mark W Kroll insider trades: Haemonetics (HAE) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mark reports to the SEC
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 10, 2025 | HAE | ↑ Buy | 1,400 | $70.56 | $99K | Direct | Nov 12, 2025 (2d) |
| Mar 7, 2023 | AXON | ↓ Sell | 3,549 | $220.73 | $783K | Direct | Mar 8, 2023 (1d) |
| Aug 15, 2022 | HAE | ↓ Sell | 8,016 | $73.71 | $591K | Direct | Aug 16, 2022 (1d) |
| Jun 8, 2022 | AXON | ↓ Sell | 3,159 | $102.82 | $325K | Direct | Jun 9, 2022 (1d) |
| May 26, 2021 | HAE | ↓ Sell | 11,813 | $55.10 | $651K | Direct | May 28, 2021 (2d) |
| May 12, 2021 | AXON | ↓ Sell | 4,204 | $124.94 | $525K | Direct | May 14, 2021 (2d) |
| Nov 16, 2020 | AAXN | ↓ Sell | 2,993 | $120.44 | $360K | Direct | Nov 17, 2020 (1d) |
| Apr 9, 2020 | HAE | ↓ Sell | 10,902 | $102.00 | $1.1M | Direct | Apr 13, 2020 (4d) |
| Nov 13, 2019 | AAXN | ↓ Sell | 4,168 | $64.30 | $268K | Direct | Nov 14, 2019 (1d) |
| Nov 7, 2018 | HAE | ↓ Sell | 10,707 | $114.00 | $1.2M | Direct | Nov 9, 2018 (2d) |
| Aug 20, 2018 | AAXN | ↓ Sell | 7,097 | $64.34 | $457K | Direct | Aug 20, 2018 (0d) |
| Jan 2, 2018 | HAE | ↓ Sell | 7,118 | $63.00 | $448K | Direct | Jan 3, 2018 (1d) |
| May 15, 2017 | HAE | ↓ Sell | 8,580 | $41.49 | $356K | Direct | May 17, 2017 (2d) |
| Feb 27, 2015 | HAE | ↓ Sell | 11,328 | $44.80 | $507K | Direct | Mar 3, 2015 (4d) |
| Dec 16, 2014 | AAXN | ↓ Sell | 3,100 | $22.85 | $71K | Direct | Jun 29, 2018 (1291d) |
| Nov 19, 2012 | HAE | ↓ Sell | 4,592 | $80.13 | $368K | Direct | Nov 21, 2012 (2d) |
| Nov 16, 2012 | HAE | ↓ Sell | 6,000 | $79.67 | $478K | Direct | Nov 20, 2012 (4d) |
| May 4, 2012 | HAE | ↓ Sell | 20,000 | $71.09 | $1.4M | Direct | May 8, 2012 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Mark W Kroll's insider trades
Mark W Kroll is a director at Haemonetics (HAE). Since May 4, 2012, Mark has reported 1 open-market purchase worth $99K and 17 sales worth $9.9M on SEC Form 4. In the last 12 months: 1 buy ($99K).
Their filings also include grants and awards (38 filings), option exercises (17 filings), gifts (7 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HAE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.